Lubberman F, Gelderblom H, Hamberg P, et al. A reduced pazopanib dose with food: Is it more patient-friendly and does it reduce drug costs? ASCO Annual Meeting 2019, abstract 4564.
Adjuvant dabrafenib plus trametinib bij stadium III-melanoom: 10 jaar follow-up
aug 2024 | Dermato-oncologie